Epidemiology of gynecologic cancers in China

Journal of Gynecologic Oncology

Volumn 29, Issue 1, 2018, Pages

  Jiang, Xiyi ^a   Tang, Huijuan ^a   Chen, Tianhui ^a,b  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b NINGBO UNIVERSITY   (China)

Author keywords

China; Epidemiology; Female; Genital Neoplasms; Incidence; Mortality; Survival

Indexed keywords

AGE STANDARDIZED INCIDENCE RATE; AGE STANDARDIZED MORTALITY RATE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CHINA; ENDOMETRIUM CANCER; FEMALE GENITAL TRACT CANCER; HUMAN; OVARY CANCER; PREVALENCE; REVIEW; SURVIVAL RATE; UTERINE CERVIX CANCER; FEMALE; FEMALE GENITAL TRACT TUMOR; INCIDENCE; REGISTER;

CHINA; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INCIDENCE; PREVALENCE; REGISTRIES; SURVIVAL RATE;

EID: 85036563188     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2018.29.e7     Document Type: Review

References (22)

1. Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in China, 2011. Chin J Cancer Res 2015;27:2-12. PUBMED | CROSSREF
2. Zheng R, Zeng H, Zhang S, Chen T, Chen W. National estimates of cancer prevalence in China, 2011. Cancer Lett 2016;370:33-8. PUBMED | CROSSREF
3. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115-32. PUBMED | CROSSREF
4. National Bureau of Statistics of China. China statistical yearbook 2010. Beijing: China Statistics Press; 2010.
5. Hu SY, Zheng RS, Zhao FH, Zhang SW, Chen WQ, Qiao YL. Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989–2008. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2014;36:119-25. PUBMED
6. Chen W, Zheng R, Zhang S, Zeng H, Xia C, Zuo T, et al. Cancer incidence and mortality in China, 2013. Cancer Lett 2017;401:63-71. PUBMED | CROSSREF
7. Liu X, Feng A, Cui Y, Tobe RG. Prevention of human papillomavirus (HPV) infection and cervical cancer in China: how does HPV vaccination bring about benefits to Chinese women? Biosci Trends 2013;7:159-67. PUBMED
8. Li S, Hu T, Lv W, Zhou H, Li X, Yang R, et al. Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group. Oncologist 2013;18:1101-7. PUBMED | CROSSREF
9. Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer 2012;131:2929-38. PUBMED | CROSSREF
10. Wang R, Guo XL, Wisman GB, Schuuring E, Wang WF, Zeng ZY, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis 2015;15:257. PUBMED | CROSSREF
11. Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, et al. Cancer survival in China, 2003–2005: a population-based study. Int J Cancer 2015;136:1921-30. PUBMED | CROSSREF
12. Cheung FY, Mang OW, Law SC. A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong: 1997–2006. Hong Kong Med J 2011;17:89-95. PUBMED
13. Wernli KJ, Ray RM, Gao DL, De Roos AJ, Checkoway H, Thomas DB. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control 2006;17:949-55. PUBMED | CROSSREF
14. Gao J, Yang G, Wen W, Cai QY, Zheng W, Shu XO, et al. Impact of known risk factors on endometrial cancer burden in Chinese women. Eur J Cancer Prev 2016;25:329-34. PUBMED | CROSSREF
15. Huang CY, Chen CA, Chen YL, Chiang CJ, Hsu TH, Lin MC, et al. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan. PLoS One 2012;7:e51372. PUBMED | CROSSREF
16. Salehi F, Dunfield L, Phillips KP, Krewski D, Vanderhyden BC. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev 2008;11:301-21. PUBMED | CROSSREF
17. Zhang S, Xia Q, Zheng R, Chen W. Incidence and mortality of ovarian cancer in China, 2010. China Cancer 2016;25:169-73.
18. Wong KH, Mang OW, Au KH, Law SC. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study. Hong Kong Med J 2012;18:466-74. PUBMED
19. Chen WQ, Zheng RS, Zeng HM, Zhang SW, Zhao P, He J. Trend analysis and projection of cancer incidence in China between 1989 and 2008. Zhonghua Zhong Liu Za Zhi 2012;34:517-24. PUBMED
20. Li L, Ji J, Wang JB, Niyazi M, Qiao YL, Boffetta P. Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy. Chin J Cancer Res 2012;24:9-17. PUBMED | CROSSREF
21. Zeng HM, Zheng RS, Zhang SW, Zhao P, He J, Chen WQ. Trend analysis of cancer mortality in China between 1989 and 2008. Zhonghua Zhong Liu Za Zhi 2012;34:525-31. PUBMED
22. Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, et al. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer 2011;11:292. PUBMED | CROSSREF